Washington Trust Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-500
Closed -$45K 275
2019
Q1
$45K Sell
500
-200
-29% -$17.3K 0.01% 350
2018
Q4
$59K Hold
700
0.01% 324
2018
Q3
$76K Hold
700
0.01% 322
2018
Q2
$77K Buy
700
+200
+40% +$20.8K 0.01% 335
2018
Q1
$50K Hold
500
0.01% 401
2017
Q4
$49K Sell
500
-35
-7% -$3.32K 0.01% 428
2017
Q3
$50K Buy
535
+35
+7% +$3.72K 0.01% 413
2017
Q2
$56K Hold
500
0.01% 361
2017
Q1
$49K Sell
500
-13
-3% -$1.24K 0.01% 397
2016
Q4
$47K Hold
513
0.01% 395
2016
Q3
$43K Buy
513
+13
+3% +$1.09K 0.01% 397
2016
Q2
$41K Hold
500
0.01% 398
2016
Q1
$36K Hold
500
0.01% 423
2015
Q4
$36K Hold
500
0.01% 440
2015
Q3
$31K Hold
500
0.01% 468
2015
Q2
$36K Hold
500
0.01% 476
2015
Q1
$38K Hold
500
0.01% 481
2014
Q4
$34K Hold
500
0.01% 530
2014
Q3
$30K Hold
500
0.01% 537
2014
Q2
$29K Hold
500
0.01% 565
2014
Q1
$29K Buy
+500
New +$26.8K 0.01% 556

Other funds holding DGX

Washington Trust Bank's DGX Position: Q2 2019 in Review

Washington Trust Bank sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 500 shares — an estimated $45K sold.

Washington Trust Bank first reported a position in DGX in Q1 2014 and held it in 21 quarters. The position peaked at $77K in Q2 2018. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Washington Trust Bank reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Washington Trust Bank sold 500 Quest Diagnostics shares in Q2 2019, an estimated $45K.
  • Washington Trust Bank first reported a position in Quest Diagnostics in Q1 2014 and held it in 21 quarters.
  • Washington Trust Bank's Quest Diagnostics position peaked at $77K in Q2 2018.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.